1[1]Wertheimer M, Hughes RK, Castle H. Superior vena cava syndrome:complication of permanent transvenous endocardial pacing[ J]. JAMA,1973,224:1172
2[2]Mazzetti H, Dussaut A, Tentori C, et al. Superior vena cava occlusion and/or syndrome related to pacemaker leads[J]. Am Heart J, 1993,125(3):831
3[3]Lindsay HS, Chennells PM, Perrins EJ. Successful treatment by balloon venoplasty and stent insertion of obstruction of the superior vena cava by an endocardial pacemaker lead[J]. Br Heart J, 1994, 71 (4): 363
4[4]Francis CM, Starkey IR, Errington ML, et al. Venous stenting as treat ment for pacemaker-induced superior vena cava syndrome[J]. Am Heart J, 1995,129(4) :836
5[5]Rosenthal E, Qureshi SA, Tynan M, et al. Percutaneous pacemaker lead extraction and stent implatation for superior vena cava occlusion due to pacemaker leads[J] .Am J Cardiol, 1996,77(8):670
6[6]Melikian N, Brookes CI, Rickards AF. Management of superior vena cava obstruction secondary to a pacingwire with percutaneous intravascular stent insertion[J]. Heart, 1999,82(2): 182
7[7]Lee TM, Su SF, Chien KL, et al. Left atrial spontaneous echo contrast in patients with permanent pacemakers[J]. Heart, 1997,78(3) :262
8[8]Ito T, Tanouchi J, Kato J, et al. Prethrombotic state due to hypercoagula bility in patients with permanent transvenous pacemakers[J]. Angiology,1997,48(10) :901
9[9]Lau CP, Tse HF, Cheng G. Effects of atrioventricular asynchrony on platelet activation implication of thromboembolism in paced patients[ J]. Heart, 1997,78(4) :358
10[10]Abe H, Takahara K, Nakashima Y, et al. Effect of low dose aspirin on augmented plasminogen activator inhibitor type I activity in patients with permanent pacemakers[J]. PACE, 1994, 17(2): 146
